Nexalin Technology Stock (NASDAQ: NXL) stock price, news, charts, stock research, profile.
Open | $1.15 |
Close | $1.24 |
Volume / Avg. | 258.27K / 2.76M |
Day Range | 1.13 - 1.30 |
52 Wk Range | 0.25 - 4.05 |
Market Cap | $12.66M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 0.83% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Nexalin Technology (NASDAQ:NXL) through any online brokerage.
Other companies in Nexalin Technology’s space includes: ENDRA Life Sciences (NASDAQ:NDRA), Predictive Oncology (NASDAQ:POAI), Bluejay Diagnostics (NASDAQ:BJDX), Venus Concept (NASDAQ:VERO) and Talis Biomedical (NASDAQ:TLIS).
There is no analysis for Nexalin Technology.
There is no analysis for Nexalin Technology to provide a consensus price target.
The stock price for Nexalin Technology (NASDAQ: NXL) is $1.1962 last updated July 26, 2024 at 7:17 PM EDT.
There are no upcoming dividends for Nexalin Technology.
Nexalin Technology’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Nexalin Technology.
Nexalin Technology is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.